Back
Rocket Pharmaceuticals Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
51
RCKT
Rocket Pharmaceuticals
Last Price:
20.16
Seasonality Move:
26.74%
Buy
57
PHAT
Phathom Pharmaceuticals
Last Price:
18.48
Seasonality Move:
-11.94%
Buy
51
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $20.17. The Score for RCKT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $18.43. The Score for PHAT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $20.17
The current trend is relatively stagnant and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $18.43
The current trend is moderately bullish and PHAT is experiencing slight selling pressure.
RCKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 51.81 | Buy |
| Chaikin Money Flow: | -602413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.36 - 20.24) | Buy |
| Bollinger Bands (100): | (19.45 - 23.35) | Sell |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 63.92 | Buy |
| Chaikin Money Flow: | -122643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.13 - 18.75) | Buy |
| Bollinger Bands (100): | (9.5 - 15.04) | Buy |
RCKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.13 | Buy |
| 20-day SMA: | 19.33 | Buy |
| 50-day SMA: | 20.69 | Sell |
| 200-day SMA: | 24.41 | Sell |
| 8-day EMA: | 20.26 | Sell |
| 20-day EMA: | 19.81 | Buy |
| 50-day EMA: | 20.32 | Sell |
| 200-day EMA: | 22.21 | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.78 | Sell |
| 20-day SMA: | 17.36 | Buy |
| 50-day SMA: | 14.08 | Buy |
| 200-day SMA: | 10.56 | Buy |
| 8-day EMA: | 18.5 | Sell |
| 20-day EMA: | 17.25 | Buy |
| 50-day EMA: | 14.92 | Buy |
| 200-day EMA: | 11.77 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.25 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Rocket Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||